In February 2024, the FDA approved Xolar (omalizumab), a drug previously approved for the treatment of moderate to severe persistent asthma, for patients to use following accidental exposure to foods.
6 whether to clear Novo Holdings’ acquisition of contract drug manufacturer Catalent ... in Novo Nordisk put in a request for EU approval for the deal on Oct. 31. The EU antitrust regulators ...
On Tuesday, the court approved the sale of Tupperware to a group of lenders, a move intended to lift the brand from Chapter 11 bankruptcy protection and allowing it to continue operations while ...
The FDA has approved the first abuse-deterrent ... “When manipulated, our innovative technology renders the pill more difficult to misuse or abuse, such as being cut or crushed to snort or ...
Assuming FDA authorization, the U.S. government has agreed to buy enough of the pills to treat 1.7 million people, at a price of roughly $700 for each course of treatment.
The United States has approved a potential $2 billion arms sale package to Taiwan, the Pentagon said on Friday, including the delivery for the first time to the island of an advanced air defense ...